back top
Termis Survey: 2014 cellular and engineered tissue therapies in Europe

1300 members from 70 countries Join ICRS

News

We continue to collect data to establish a comprehensive, quantitative map of patients being treated in Europe with cellular and engineered tissue therapies (i.e. any clinical treatment based on living cells excluding DLI, donor lymphocyte infusions, and hematopoietic stem cells for hematological reconstitution). The survey is supported by the 6 international organisations shown above and integrates the original EBMT activity survey capturing hematopoietic stem cells transplants in Europe.

Termis Survey: 2014 cellular and engineered tissue therapies in Europe

Termis Survey: 2014 cellular and engineered tissue therapies in Europe

20/10/2015